The NCCN Cancer-Related Fatigue (CRF) Scientific Research Committee was convened in September 2009 to accomplish 3 objectives: 1) review the current methods to measure and interventions to treat CRF; 2) recommend a CRF measure or develop a new measure for a future research project; and 3) discuss how to proceed with a CRF research project to parallel the NCCN Oncology Outcomes Database. This report summarizes the committee's work and will guide the planned CRF research project.
BarsevickAMCleelandCSManningDC. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage2010;39:1086–1099.
BergerAAbernethyAAtkinsonA. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. Version 1.2010. Available at: www.NCCN.org. Last accessed November 10 2010.
CellaDDavisKBreitbartWCurtG. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a united states sample of cancer survivors. J Clin Oncol2001;19:3385–3391.
SadlerIJJacobsenPBBooth-JonesM. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manage2002;23:406–416.
LoscalzoMJClarkKL. Problem-related distress in cancer patients drives requests for help: a prospective study. Oncology (Williston Park)2007;21:1133–1138.
SoWKMarshGLingWM. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. Oncol Nurs Forum2009;36:E205–214.
Gaston-JohanssonFFall-DicksonJMBakosABKennedyMJ. Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract1999;7:240–247.
DittnerAJWesselySCBrownRG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res2004;56:157–170.
HjollundNHAndersenJHBechP. Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales. Health Qual Life Outcomes2007;5:12.
Jean-PierrePFigueroa-MoseleyCDKohliS. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist2007;12:11–21.
MintonOStoneP. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol2009;20:17–25.
BroderickJESchwartzJEVikingstadG. The accuracy of pain and fatigue items across different reporting periods. Pain2008;139:146–157.
KangasMBovbjergDHMontgomeryGH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull2008;134:700–741.
GoedendorpMGielissenMVerhagenCBleijenbergG. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev2009:CD006953.
JacobsenPDonovanKVadaparampilSSmallB. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol2007;26:660–667.
American Society of Clinical Oncology. Coping with cancer-related fatigue. Available at: http://www.cancer.net/patient/All+About+Cancer/Cancer.Net+Feature+Articles/Side+Effects/Coping+With+Cancer-Related+Fatigue. Accessed November 10 2010.
RavascoPMonteiro-GrilloIVidalPMCamiloME. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol2005;23:1431–1438.
EpsteinDDirksenS. Randomized trial of a cognitive-behavioral intervention for insomnia in breast cancer survivors. Oncol Nurs Forum2007;34:E51–59.
EspieCAFlemingLCassidyJ. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol2008;26:4651–4658.
SarhillNWalshDNelsonK. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care2001;18:187–192.
BrueraEValeroVDriverL. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol2006;24:2073–2078.
LowerEFleishmanSCooperA. A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and ``chemobrain'' in adult cancer patients [abstract]. J Clin Oncol2005;23(Suppl 1):Abstract 8000.
MintonORichardsonASharpeM. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst2008;100:1155–1166.
MoraskaARSoodADakhilSR. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial. J Clin Oncol2010;28:3673–3679.
MorrowGGilliesLHickokJ. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed [abstract]. J Clin Oncol2005;23(Suppl 1):Abstract 8012.
MorrowGJean-PierrePRoscoeJ. A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: a URCC CCOP study [abstract]. J Clin Oncol2008;26(Suppl 1):Abstract 9512.
BlackhallLPetroniGShuJ. A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med2009;12:433–439.
Della CunaGRPellegriniAPiazziM. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol1989;25:1817–1821.
JunejaVKeeganPGootenbergJ. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res2008;14:3242–3247.
WelsteinLDementWRedingtonDGuilleminaultC. Insomnia in the San Francisco Bay Area: a telephone survey. In: GuilleminaultCLugaresiE eds. Sleep/Wake Disorders: Natural History Epidemiology and Long-Term Evolution. New York, NY: Raven Press; 1983:73–85.
SwarmRAbernethyAAnghelescuDL. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 1.2010. Available at: http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf. Accessed November 10 2010.
HollandJCAndersenBBreitbartWS. NCCN Clinical Practice Guidelines in Oncology: Distress Management. Version 1.2011. Available at: http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf. Accessed November 10 2010.
YellenSBCellaDFWebsterK. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage1997;13:63–74.
PiperBDibbleSDoddM. The Revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum1998;25:677–684.